Phenylephrine Hydrochloride Injection
FDA Label NDC 55154-8226

34 label sections · Submitted to the FDA by Cardinal Health 107, Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Cardinal Health 107, Llc for the product Phenylephrine Hydrochloride (NDC 55154-8226). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding 1 indications and usage, 2.1 general dosage and administration instructions, 2.2 dosing for treatment of hypotension during anesthesia, 2.3 prepare a 100 mcg/ml solution for bolus intravenous administration, 2.4 prepare a solution for continuous intravenous administration, 3 dosage forms and strengths, 4 contraindications, 5.1 exacerbation of angina, heart failure, or pulmonary arterial hypertension, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package/Label Display Panel

NDC 55154-8226-5

PHENYLEPHRINE HYDROCHLORIDE

INJECTION, USP 10 mg/mL

5 x 1 mL SINGLE-DOSE VIALS

10mg/ml Bag Label (Afc3a900 5704 4744 9e6b 0fe0a8fd0119 00)

10mg/ml Bag Label (Afc3a900 5704 4744 9e6b 0fe0a8fd0119 00)

* Please review the disclaimer below.